Zy Therapeutics
PrivateLast Round
Corporate Funding
Feb 2, 2020
Est. Valuation
$10M
Total Funding Raised
$9M
Company Overview
Zy Therapeutics is a biotechnology company developing ZY-001, a therapy to directly target brain calcifications for rare central nervous system (CNS) disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zy Therapeutics Comparables
Compare Zy Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QurCan Therapeutics | 86% | |
| Optimeos Life Sciences | 85% | |
| Xanadu Bio | 76% | |
Zy Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Feb 2, 2020 | ||||
| Strategic | Sep 19, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 439% MoM, from 346 to 1.9K.
Zy Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zy Therapeutics's valuation, stock price, and market status.